← Back to Search

Procedure

Wavefront-guided vs. Optimized LASIK for Myopia

N/A
Waitlist Available
Led By Edward E. Manche, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects age 21 and older with healthy eyes
Be between 18 and 65 years old
Must not have
Subjects under the age of 21
Patients with excessively thin corneas
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing the outcomes of two different types of LASIK surgery in patients with nearsightedness with and without astigmatism.

Who is the study for?
This trial is for adults over 21 with healthy eyes who have nearsightedness ranging from very mild to severe (-0.25 to -11.00 diopters), with or without astigmatism up to 5.00 diopters. It's not suitable for those with certain eye conditions like keratoconus, pregnant or nursing individuals, people under 21, those with thin corneas, significant differences in vision between eyes, or autoimmune diseases.
What is being tested?
The study is examining the effectiveness of two types of LASIK surgery: one using a high definition wavefront-guided laser and the other using a wavefront-optimized laser. The goal is to see which method provides better results for correcting nearsightedness and astigmatism.
What are the potential side effects?
LASIK surgery may cause dry eyes, glare, halos around lights at night-time, fluctuating vision during recovery period and rarely more serious complications such as loss of vision.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 or older with healthy eyes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 21 years old.
Select...
My corneas are very thin.
Select...
I have been diagnosed with keratoconus.
Select...
I have an eye condition where my eye shape is abnormal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: iDesign WFG LASIKActive Control1 Intervention
Wavefront-guided LASIK
Group II: Wavelight WFO LASIKActive Control1 Intervention
Wavefront-optimized LASIK

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,468 Previous Clinical Trials
17,496,182 Total Patients Enrolled
5 Trials studying Astigmatism
926 Patients Enrolled for Astigmatism
Edward E. Manche, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
700 Total Patients Enrolled
1 Trials studying Astigmatism
700 Patients Enrolled for Astigmatism

Media Library

High Resolution Wavefront-guided LASIK (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT02565537 — N/A
Astigmatism Research Study Groups: iDesign WFG LASIK, Wavelight WFO LASIK
Astigmatism Clinical Trial 2023: High Resolution Wavefront-guided LASIK Highlights & Side Effects. Trial Name: NCT02565537 — N/A
High Resolution Wavefront-guided LASIK (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02565537 — N/A
~10 spots leftby Nov 2025